74476-70-3

Basic information

• Product Name: 2-chloro-3-(4-fluorophenyl)-3-oxopropanoic acid
• Synonyms: 2-chloro-3-(4-fluorophenyl)-3-oxopropanoic acid
• CAS NO: 74476-70-3
• Molecular Formula: C₁₁H₁₀ClFO₃
• Molecular Weight: 216.5935432
• Mol File: 74476-70-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-chloro-3-(4-fluorophenyl)-3-oxopropanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-chloro-3-(4-fluorophenyl)-3-oxopropanoic acid(74476-70-3)
• EPA Substance Registry System: 2-chloro-3-(4-fluorophenyl)-3-oxopropanoic acid(74476-70-3)

Safety Data

• Hazardous Substances Data: 74476-70-3(Hazardous Substances Data)

Upstream product

• 1999-00-4 ethyl 3-(4'-fluorophenyl)-3-oxopropionate 
• 403-42-9 1-(4-fluorophenyl)ethanone 

Downstream Products

• 74476-50-9 ethyl 2-amino-4-(p-fluorophenyl)-5-thiazolecarboxylate 
• 74476-51-0 ethyl 2-chloro-4-(p-fluorophenyl)-5-thiazolecarboxylate 
• 347173-47-1 4-(4-fluoro-phenyl)-2-methyl-thiazole-5-carboxylic acid ethyl ester 
• 1333321-09-7 ethyl 2-acetoxy-3-(4-fluorophenyl)-3-(4-methoxyphenylamino)propanoate 
• 1333320-91-4 ethyl 2-acetoxy-3-(4-fluorophenyl)-3-(4-methoxyphenylamino)acrylate 

Relevant articles and documents

Highly diastereoselective and enantioselective synthesis of α-hydroxy β-amino acid derivatives: Lewis base catalyzed hydrosilylation of α-acetoxy β-enamino esters

By design: A series of α-acetoxy-β-enamino esters 1 were synthesized and then subjected to catalytic asymmetric hydrosilylation. In the presence of a chiral Lewis base catalyst, the reactions proceeded smoothly to provide a wide range of chiral α-acetoxy β-amino acid derivatives in high yields with good diastereoselectivities and enantioselectivities. Copyright

PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES

The invention relates to novel phenethylamide derivatives and their heterocyclic analogues of formula (I), wherein A, B, R1, R2 and R3 are as described in the application, and to the use of such compounds, or of pharmaceut

PYRAZOLE COMPOUNDS AND USE THEREOF

The pyrazole compound of the present invention is represented by the following general formula (I). The pyrazole compound of the present invention or a salt thereof or a solvate thereof potently inhibits liver glycogen phosphorylase, and, therefore, is useful as a therapeutic or prophylactic agent for diabetes. wherein each symbol denotes as described in the specifications.